Phase III: NSCLC
FOCUS AREA
NON-SMALL CELL LUNG CANCER
DEVELOPMENT STAGE
PHASE I
TARGET
4
Title
Order
2
Subtitle pipeline
Cancer cell-directed
SEO Description
HER2 exon 20 inhibitor (BI 1810631)